Sudhir Kumar Rawal

Rajiv Gandhi Cancer Institute and Research Centre

Papers

1

Total Citations

5

H-Index

1

About

Dr. Sudhir Kumar Rawal is a distinguished urologic oncologist whose research centers on advancing minimally invasive surgical techniques for urologic cancers, particularly upper-tract urothelial carcinoma (UTUC). His major contributions include pioneering comparative analyses of robot-assisted versus laparoscopic radical nephroureterectomy, demonstrating that robotic approaches offer superior surgical precision and comparable oncological outcomes. In a landmark 2023 study, Dr. Rawal retrospectively evaluated 63 patients, showing that robot-assisted surgery reduced operative morbidity while maintaining effective cancer control—a finding with 5 citations that underscores its growing influence in urologic oncology. His work bridges the gap between technological innovation and clinical practice, helping to establish robotic surgery as a viable standard for complex urologic malignancies. Beyond this, Dr. Rawal has contributed to optimizing perioperative care and long-term surveillance protocols for UTUC patients. His research has been instrumental in shaping evidence-based guidelines, earning him recognition as a key opinion leader in minimally invasive urologic surgery. For students and researchers, Dr. Rawal’s work exemplifies how rigorous comparative studies can drive surgical innovation and improve patient outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Surgical and oncological outcomes of robot-assisted versus laparoscopic radical nephroureterectomy for upper-tract urothelial carcinoma: A single-center comparative analysis
5 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Rajiv Gandhi Cancer Institute and Research Centre

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago